Cargando…

Stem Cells Therapy for Spinal Cord Injury

Spinal cord injury (SCI), a serious public health issue, most likely occurs in previously healthy young adults. Current therapeutic strategies for SCI includes surgical decompression and pharmacotherapy, however, there is still no gold standard for the treatment of this devastating condition. Ineffi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gazdic, Marina, Volarevic, Vladislav, Harrell, C. Randall, Fellabaum, Crissy, Jovicic, Nemanja, Arsenijevic, Nebojsa, Stojkovic, Miodrag
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5979319/ https://www.ncbi.nlm.nih.gov/pubmed/29601528 http://dx.doi.org/10.3390/ijms19041039

Ejemplares similares

Role of indoleamine 2,3-dioxygenase in pathology of the gastrointestinal tract
por: Acovic, Aleksandar, et al.
Publicado: (2018)

Mesenchymal Stem Cell-Based Therapy of Inflammatory Lung Diseases: Current Understanding and Future Perspectives
por: Harrell, C. Randall, et al.
Publicado: (2019)

Molecular Mechanisms Responsible for Therapeutic Potential of Mesenchymal Stem Cell-Derived Secretome
por: Harrell, Carl Randall, et al.
Publicado: (2019)

Stem Cells and Labeling for Spinal Cord Injury
por: Gazdic, Marina, et al.
Publicado: (2016)

Galectin 3 protects from cisplatin-induced acute kidney injury by promoting TLR-2-dependent activation of IDO1/Kynurenine pathway in renal DCs
por: Volarevic, Vladislav, et al.
Publicado: (2019)

Ethical and Safety Issues of Stem Cell-Based Therapy
por: Volarevic, Vladislav, et al.
Publicado: (2018)

Molecular mechanisms of cisplatin-induced nephrotoxicity: a balance on the knife edge between renoprotection and tumor toxicity
por: Volarevic, Vladislav, et al.
Publicado: (2019)

Mesenchymal Stem Cells as New Therapeutic Agents for the Treatment of Primary Biliary Cholangitis
por: Arsenijevic, Aleksandar, et al.
Publicado: (2017)

Indoleamine 2,3-dioxygenase-dependent expansion of T-regulatory cells maintains mucosal healing in ulcerative colitis
por: Acovic, Aleksandar, et al.
Publicado: (2018)

Mesenchymal Stem Cell-Derived Exosomes and Other Extracellular Vesicles as New Remedies in the Therapy of Inflammatory Diseases
por: Harrell, Carl Randall, et al.
Publicado: (2019)

Mesenchymal Stem Cells Attenuate Cisplatin-Induced Nephrotoxicity in iNOS-Dependent Manner
por: Simovic Markovic, Bojana, et al.
Publicado: (2017)

Mesenchymal Stem Cell-Dependent Modulation of Liver Diseases
por: Gazdic, Marina, et al.
Publicado: (2017)

Galectin-3 Regulates Indoleamine-2,3-dioxygenase-Dependent Cross-Talk between Colon-Infiltrating Dendritic Cells and T Regulatory Cells and May Represent a Valuable Biomarker for Monitoring the Progression of Ulcerative Colitis
por: Volarevic, Vladislav, et al.
Publicado: (2019)

Therapeutic Potential of Mesenchymal Stem Cells and Their Secretome in the Treatment of Glaucoma
por: Harrell, C. Randall, et al.
Publicado: (2019)

Mesenchymal Stem Cells Promote Metastasis of Lung Cancer Cells by Downregulating Systemic Antitumor Immune Response
por: Gazdic, Marina, et al.
Publicado: (2017)

Molecular mechanisms underlying therapeutic potential of pericytes
por: Harrell, C. Randall, et al.
Publicado: (2018)

Concise Review: Mesenchymal Stem Cell Treatment of the Complications of Diabetes Mellitus
por: Volarevic, Vladislav, et al.
Publicado: (2011)

Pharmacological Inhibition of Gal-3 in Mesenchymal Stem Cells Enhances Their Capacity to Promote Alternative Activation of Macrophages in Dextran Sulphate Sodium-Induced Colitis
por: Simovic Markovic, Bojana, et al.
Publicado: (2016)

Risks of Using Sterilization by Gamma Radiation: The Other Side of the Coin
por: Harrell, C. Randall, et al.
Publicado: (2018)

Molecular and Cellular Mechanisms Responsible for Beneficial Effects of Mesenchymal Stem Cell-Derived Product “Exo-d-MAPPS” in Attenuation of Chronic Airway Inflammation
por: Harrell, Carl Randall, et al.
Publicado: (2020)

Therapeutic Use of Mesenchymal Stem Cell-Derived Exosomes: From Basic Science to Clinics
por: Harrell, Carl Randall, et al.
Publicado: (2020)

Mesenchymal Stem Cell: A Friend or Foe in Anti-Tumor Immunity
por: Harrell, Carl Randall, et al.
Publicado: (2021)

Stem Cells as New Agents for the Treatment of Infertility: Current and Future Perspectives and Challenges
por: Volarevic, Vladislav, et al.
Publicado: (2014)

Human mesenchymal stem cells creating an immunosuppressive environment and promote breast cancer in mice
por: Ljujic, Biljana, et al.
Publicado: (2013)

Molecular Mechanisms Responsible for Mesenchymal Stem Cell-Based Treatment of Viral Diseases
por: Harrell, Carl Randall, et al.
Publicado: (2021)

Stem Cell-Based Therapy in Transplantation and Immune-Mediated Diseases
por: Volarevic, Vladislav, et al.
Publicado: (2017)

Stem Cells, Inflammation, and Fibrosis
por: Volarevic, Vladislav, et al.
Publicado: (2016)

Therapeutic Potential of Mesenchymal Stem Cells and Their Secretome in the Treatment of SARS-CoV-2-Induced Acute Respiratory Distress Syndrome
por: Harrell, Carl Randall, et al.
Publicado: (2020)

The Effects of Mesenchymal Stem Cells on Antimelanoma Immunity Depend on the Timing of Their Administration
por: Miloradovic, Dragana, et al.
Publicado: (2020)

Galectin-3 and IL-33/ST2 axis roles and interplay in diet-induced steatohepatitis
por: Pejnovic, Nada, et al.
Publicado: (2016)

IL-33 Prevents MLD-STZ Induction of Diabetes and Attenuate Insulitis in Prediabetic NOD Mice
por: Pavlovic, Sladjana, et al.
Publicado: (2018)

Mesenchymal Stem Cell-Derived Exosomes as New Remedy for the Treatment of Neurocognitive Disorders
por: Harrell, Carl Randall, et al.
Publicado: (2021)

Differential Immunometabolic Phenotype in Th1 and Th2 Dominant Mouse Strains in Response to High-Fat Feeding
por: Jovicic, Nemanja, et al.
Publicado: (2015)

Therapeutic Potential of Exosomes Derived from Adipose Tissue-Sourced Mesenchymal Stem Cells in the Treatment of Neural and Retinal Diseases
por: Harrell, Carl Randall, et al.
Publicado: (2022)

Deletion of IL-33R (ST2) Abrogates Resistance to EAE in BALB/C Mice by Enhancing Polarization of APC to Inflammatory Phenotype
por: Milovanovic, Marija, et al.
Publicado: (2012)

The Cross-Talk between Mesenchymal Stem Cells and Immune Cells in Tissue Repair and Regeneration
por: Harrell, Carl Randall, et al.
Publicado: (2021)

Therapeutic Potential of Mesenchymal Stem Cells in the Treatment of Ocular Graft-Versus-Host Disease
por: Harrell, Carl Randall, et al.
Publicado: (2022)

Therapeutic potential of mesenchymal stem cells in the treatment of acute liver failure
por: Harrell, Carl Randall, et al.
Publicado: (2022)

Connexin 50 Expression in Ependymal Stem Progenitor Cells after Spinal Cord Injury Activation
por: Rodriguez-Jimenez, Francisco Javier, et al.
Publicado: (2015)

NLRP3 Inflammasome as a Potentially New Therapeutic Target of Mesenchymal Stem Cells and Their Exosomes in the Treatment of Inflammatory Eye Diseases
por: Harrell, Carl Randall, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_lc8b216gldcb1si6vh824ksd70